Editorial board disclosure policy

(last updated March 2019)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Dr Michael Bryer-Ash
Dr Bryer-Ash holds shares in Dexcom Inc, a maker of continuous glucose sensors, and is also a minor shareholder in Pfizer Pharmaceuticals Inc. Effective June 2019, he will also be an unpaid Member of the Governing Board of Iowa Tribe of Kansas’ Tribal Health System; a small Native American tribal health system in the state of Kansas, USA, serving exclusively Native American patients.
Professor Daniel Chen
Professor Chen has received personal fees from Besin and Inova and also non-financial support from Amgen.
Dr Maria Fleseriu
Dr Fleseriu has received research grants from Pfizer, Millendo, Strongbridge, Ionis, Chiasma, Novartis and Novo Nordisk. She has also received fees for scientific consulting for Pfizer, Strongbridge, Ionis, Chiasma, Novartis, Novo Nordisk and Ipsen.
Professor Wouter de Herder
Professor de Herder has received research grants from Ipsen and speakers fees from Ipsen, Pfizer and Novartis. He has also served on the Advisory Boards of Ipsen and Novartis.
Dr Warrick Inder
Dr Inder is on the advisory board of Pfizer and has received speaker honoraria from Amgen.
Professor Paul Kaplowitz
Professor Kaplowitz was paid for participation in an advisory board meeting for the liquid l-thyroxine preparation Tirosint and was also paid for his role as head of the DSMB for a Tolmar study.
Dr Fabienne Langlois
Dr Langlois currently works as a consultant for Novartis.
Dr Gefsi Mintziori
Dr Mintziori has received payment for teaching in the postgraduate programme 'Medical Research Methodology' at the Aristotle University of Thessaloniki Medical School.
Professor Salvatore Minisola
Professor Minisola has received research grants from Abiogen, Amgen and Sandoz.
Professor Luca Persani
Professor Persani received fees for consulting from Sandoz and Merck-Serono and also travel fees from Sanofi.
Dr Constantine Stratakis
Dr. Stratakis has received Pfizer grant support.
Dr Shahrad Taheri
Dr Taheri is on the advisory board for Novo Nordisk.
The following editors reported no competing interests:
  • Dr Marco Bonomi
  • Professor Isabelle Bourdeau
  • Dr Magnus Regio Dias da Silva
  • Dr Larry Distiller
  • Professor Ashley Grossman
  • Dr Sarantis Livadas
  • Dr Sofia Llahana
  • Professor Ayrton Moreira
  • Dr Karel Pacak
  • Dr Joanne Rovet
  • Dr Katerina Saltiki
  • Dr Andrew Solomon
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information please refer to our ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).